Mode
Text Size
Log in / Sign up
N/A N=96 Randomized Triple-blind Treatment

Effectiveness of Osteopathic Manipulative Therapy in Nonsynostotic Plagiocephaly

Nonsynostotic Plagiocephaly

Enrolled (actual)
96
Serious AEs
0.0%
Results posted
Sep 2020
Primary outcome: Primary: Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 3 Months — 23; 3; 25; 45 Participants — p=0.01

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Osteopathic manipulative therapy (OMTh) (Other); Light Touch Therapy (LTT) (Other); Repositioning therapy (Other)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
PRIOLO CLAUDIO
Primary completion
Feb 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 3 Months
23; 3; 22; 41 0.01 sig
PRIMARY
Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 1 Year of Age.
28; 5; 13; 31 0.01 sig
PRIMARY
Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 3 Months
23; 3; 22; 41 0.01 sig
PRIMARY
Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 1 Year of Age.
28; 5; 13; 31 0.01 sig
SECONDARY
Cranial Proportion Index (CPI)
SECONDARY
Adverse Event
0; 0; 0; 0

Summary

The aim of this trial is to evaluate the effectiveness of osteopathic manipulative therapy in reducing the asymmetries of skull in infants with nonsynostotic plagiocephaly.

Eligibility Criteria

Inclusion Criteria

  • Infants with NSP, ODDI score of 104% or more.
  • To be at term corrected age if born prematurely.

Exclusion Criteria

  • Synostotic Plagiocephaly
  • Infant who underwent an osteopathic manipulative treatment before the enrolment
  • Dysmorphisms
  • Syndromes
  • Congenital Muscular Torcicolis
  • Cerebral Palsy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03970395). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search